» Articles » PMID: 1420187

Fibril Formation by Primate, Rodent, and Dutch-hemorrhagic Analogues of Alzheimer Amyloid Beta-protein

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1992 Nov 10
PMID 1420187
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Deposition of extraneuronal fibrils that assemble from the 39-43 residue beta/A4 amyloid protein is one of the earliest histopathological features of Alzheimer's disease. We have used negative-stain electron microscopy, Fourier-transform infrared (FT-IR) spectroscopy, and fiber X-ray diffraction to examine the structure and properties of synthetic peptides corresponding to residues 1-40 of the beta/A4 protein of primate [Pm(1-40); human and monkey], rodent [Ro(1-40); with Arg5-->Gly, Tyr10-->Phe, and His13-->Arg], and hereditary cerebral hemorrhage with amyloidosis of the Dutch type (HCHWA-D) [Du(1-40); with Glu22-->Gln]. As controls, we examined a reverse primate sequence [Pm*(40-1)] and an extensively substituted primate peptide [C(1-40); with Glu3-->Arg, Arg5-->Glu, Asp7-->Val, His13-->Lys, Lys16-->His, Val18-->Asp, Phe19-->Ser, Phe20-->Tyr, Ser26-->Pro, Ala30-->Val, Ile31-->Ala, Met35-->norLeu, Gly38-->Ile, Val39-->Ala, and Val40-->Gly]. The assembly of these peptides was studied to understand the relationship between species-dependent amyloid formation and beta/A4 sequence and the effect of a naturally occurring point mutation of fibrillogenesis. The three N-terminal amino acid differences between Pm(1-40) and Ro(1-40) had virtually no effect on the morphology or organization of the fibrils formed by these peptides, indicating that the lack of amyloid deposits in rodent brain is not due directly to specific changes in its beta/A4 sequence. beta-Sheet and fibril formation, judged by FT-IR, was maximal within the pH range 5-8 for Pm(1-40), pH 5-10.5 for Du(1-40), and pH 2.5-8 for Ro(1-40).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

In-silico structural analysis of amyloid beta: an anti-Alzheimer's peptide.

Javanmard A, Azimzadeh-Irani M, Tafazzoli G, Esmaeilzadeh A, Shirinpoor-Kharf M, Haghayeghi S Mol Biol Res Commun. 2024; 13(1):29-42.

PMID: 38164365 PMC: 10644309. DOI: 10.22099/mbrc.2023.48223.1862.


Hfq C-terminal region forms a β-rich amyloid-like motif without perturbing the N-terminal Sm-like structure.

Berbon M, Martinez D, Morvan E, Grelard A, Kauffmann B, Waeytens J Commun Biol. 2023; 6(1):1075.

PMID: 37865695 PMC: 10590398. DOI: 10.1038/s42003-023-05462-1.


p53 amyloid aggregation in cancer: function, mechanism, and therapy.

Li J, Guo M, Chen L, Chen Z, Fu Y, Chen Y Exp Hematol Oncol. 2022; 11(1):66.

PMID: 36171607 PMC: 9520902. DOI: 10.1186/s40164-022-00317-7.


Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Nguyen P, Ramamoorthy A, Sahoo B, Zheng J, Faller P, Straub J Chem Rev. 2021; 121(4):2545-2647.

PMID: 33543942 PMC: 8836097. DOI: 10.1021/acs.chemrev.0c01122.


Half a century of amyloids: past, present and future.

Ke P, Zhou R, Serpell L, Riek R, Knowles T, Lashuel H Chem Soc Rev. 2020; 49(15):5473-5509.

PMID: 32632432 PMC: 7445747. DOI: 10.1039/c9cs00199a.